REVIEW
Published on 22 Jan 2024
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies
doi 10.3389/fimmu.2024.1343020
- 3,052 views
- 5 citations